2 results
Approved WMOPending
To evaluate the efficacy of AD 923 in comparison to MSIR in the management of breakthrough pain in subjects with malignicies who are taking a stable dose of background opioids.
Approved WMOPending
To assess the effectivity and safety of 1.0 molar gadobutrol (Gadovist®) for breast MRI